Keyword: Intas

India's Intas buys U.K. business and plant Teva is unloading

India’s Intas Pharmaceuticals came out on top in the bidding for operations in the U.K. and Ireland that Teva got in its $40.5 billion deal for Allergan’s generics business but was ordered by regulators to divest to keep competition fair in that part of the world.